Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Raskin

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Journal of Diabetes and Its Complications|March 1, 2006
Anthropometric features and cardiovascular risk in young Latin Americans with type 2 diabetes mellitusLarissa Avilés-Santa, Karin Salinas, Beverley Adams-Huet, et al.
Journal of Perioperative Practice|November 28, 2013
A novel glucose-insulin infusion maintains perioperative glycaemic control through multiple transitions of careNora Renthal, Erin D Roe, Beverley Adams-Huet, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 18, 2006
Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitusLarissa Avilés-Santa, Karin Salinas, Beverley Adams-Huet, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetesPatrick Litonjua, Antonio Piñero-Piloña, Larissa Aviles-Santa, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 20, 2007
Effects of multiple daily insulin injections on peripheral glucose disposal in Latin Americans with type 2 diabetes mellitusLarissa Avilés-Santa, Karin Salinas, Beverley Adams-Huet, et al.
Diabetes Care|June 23, 2012
β-cell function preservation after 3.5 years of intensive diabetes therapyLindsay B Harrison, Beverley Adams-Huet, Philip Raskin, et al.
Health and Quality of Life Outcomes|February 9, 2007
Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analoguesMeryl Brod, David Cobden, Morten Lammert, et al.
International Journal of Psychiatry in Clinical Practice|June 19, 2014
Screening for depression in a diabetic outpatient populationElla J Daly, Madhukar H Trivedi, Philip Raskin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 18, 2011
A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failureMayer B Davidson, Philip Raskin, Robert J Tanenberg, et al.
Diabetes Care|August 27, 2005
PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metforminJohn Gerich, Philip Raskin, Lisa Jean-Louis, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Journal of Diabetes and Its Complications|March 1, 2006
Anthropometric features and cardiovascular risk in young Latin Americans with type 2 diabetes mellitusLarissa Avilés-Santa, Karin Salinas, Beverley Adams-Huet, et al.
Journal of Perioperative Practice|November 28, 2013
A novel glucose-insulin infusion maintains perioperative glycaemic control through multiple transitions of careNora Renthal, Erin D Roe, Beverley Adams-Huet, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 18, 2006
Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitusLarissa Avilés-Santa, Karin Salinas, Beverley Adams-Huet, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetesPatrick Litonjua, Antonio Piñero-Piloña, Larissa Aviles-Santa, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 20, 2007
Effects of multiple daily insulin injections on peripheral glucose disposal in Latin Americans with type 2 diabetes mellitusLarissa Avilés-Santa, Karin Salinas, Beverley Adams-Huet, et al.
Diabetes Care|June 23, 2012
β-cell function preservation after 3.5 years of intensive diabetes therapyLindsay B Harrison, Beverley Adams-Huet, Philip Raskin, et al.
Health and Quality of Life Outcomes|February 9, 2007
Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analoguesMeryl Brod, David Cobden, Morten Lammert, et al.
International Journal of Psychiatry in Clinical Practice|June 19, 2014
Screening for depression in a diabetic outpatient populationElla J Daly, Madhukar H Trivedi, Philip Raskin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 18, 2011
A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failureMayer B Davidson, Philip Raskin, Robert J Tanenberg, et al.
Diabetes Care|August 27, 2005
PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metforminJohn Gerich, Philip Raskin, Lisa Jean-Louis, et al.
Pageof 13